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Identifying binding sites and target genes of transcription factors is a major biologic problem.The most
commonly used current technique, chromatin immunoprecipitation (ChIP), is dependent on a high quality
antibody for each protein of interest, which is not always available, and is also cumbersome, involving
sequential cross-linking and reversal of cross-linking.We have developed a novel strategy to study protein
DNA binding sites in vivo, which we term DamIP. By tethering a mutant form of E. coli DNA adenine
methyltransferase to the target protein, the fusion protein introduces N-6-adenosine methylation to sequences
proximal to the protein binding sites. DNA fragments with this modification, which is absent in eukaryotes,
are detected using an antibody directed against methylated adenosine. For an initial test of the method we
used human estrogen receptor α (hERα), one of the best studied transcription factors.We found that expression
of Dam-hERα fusion proteins in MCF-7 cells introduces adenosine methylation near a series of known direct
hERα binding sites. Specific methylation tags are also found at indirect hERα binding sites, including both
primary binding sites for the ER interactors AP-1 and SP1, and promoters that are activated by upstream ER
bound enhancers. DamIP provides a new tool for the study of DNA interacting protein function in vivo.
Received October 12th, 2009; Accepted March 9th, 2010; Published April 16th, 2010  | Abbreviations: CA12:carbonic anhydrase XII; ChIP:chromatin
immunoprecipitation; CTSD: cathepsin D; Dam: DNA adenine methyltransferase; DamID: Dam identification; DamIP: Dam immunoprecipitation;
ERE: estrogen response element; ERα: estrogen receptor α; FSIP: fibrous sheath interacting protein1; IGFBP1: insulin-like growth factor binding
protein 1; RMRP: RNA component of mitochondrial RNA processing endoribonuclease; SEM: standard error of mean; UGT2B15: UDP
glycosyltransferase 2B15 | Copyright © 2010, Xiao et al.This is an open-access article distributed under the terms of the Creative Commons
Non-Commercial Attribution License, which permits unrestricted non-commercial use distribution and reproduction in any medium, provided the original
work is properly cited.
Cite this article: Nuclear Receptor Signaling (2010) 8, e003
Introduction
Regulation of gene expression is a complex process
controlled by a large number of different proteins that
interact with DNA directly or indirectly. Study of how and
where these proteins bind to the genome is essential for
understanding this process. Historically, many methods
have been developed to study DNA-protein interactions
[Moss and Leblanc, 2009]. Chromatin immunoprecipitation
(ChIP) is a widely utilized method that involves chemical
cross-linking of DNA and protein followed by enriching
the DNA-protein complexes with an antibody specifically
directed against the protein of interest [Collas, 2009].
Combined with DNA microarray or massive parallel
sequencing technologies, ChIP makes it possible to profile
the occupancy of DNA interacting proteins at a genome
wide scale [Ren et al., 2000; Robertson et al., 2007].
However, the ChIP assay is rather cumbersome and is
limited by its dependence on a high quality antibody for
each protein of interest.
Recently, van Steensel and colleagues developed a new
strategy to study protein DNA interactions [Orian et al.,
2009; van Steensel et al., 2001; van Steensel and
Henikoff, 2000]. DNA adenine methyltransferase (Dam)
from E. coli, which specifically methylates the adenine
residue in a GATC recognition sequence, is attached to
the protein of interest through a short linker.When
expressed in cells, the fusion proteins bind to genomic
DNA and introduce N-6-adenine methylation to nearby
GATC tetramers. Locations of methylation can be
identified with methylation sensitive restriction enzymes
Dpn I and Dpn II.This method, named Dam IDentification
(DamID), has been successfully applied to several
eukaryotic model systems, e.g. budding yeast, plant, fruit
fly, and cultured mammalian cells [Bianchi-Frias et al.,
2004; Orian et al., 2003;Venkatasubrahmanyam et al.,
2007;Weber et al., 2005; Zhang et al., 2007].
The high activity of E. coli Dam creates a signal to noise
problem for the DamID approach. In addition, the
tetrameric Dam recognition occurs on average once in
every 256 nucleotides in the genome and may not be
present near specific DNA binding sites of interest, which
limits its resolution. DNA adenine methyltransferase has
been extensively studied and its target sequence
recognition is determined by several key amino acid
residues in the catalytic pocket [Horton et al., 2006;
Horton et al., 2005]. Previously described mutations of
these residues decrease both the activity of the enzyme
and the specificity for the GATC tetramer, thereby
increasing the frequency of potential methylation sites
and addressing both concerns. Here we describe a new
method using such a mutant form of DNA adenine
methyltransferase, combined with an antibody that
specifically recognizes N-6-methylated DNA [Lopez et
al., 2003].The mutant Dam is linked to the protein of
interest, and the fusion protein introduces N-6-adenosine
methylation to sequences adjacent to specific DNA
binding sites. Methylated DNA fragments are enriched
by immunoprecipitation and detected by quantitative real
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in an initial test of this method, and have found that
Dam-hERα fusion protein can be used to specifically
identify both direct and indirect hERα DNA binding sites.
Reagents and instruments
QuickChange site-directed mutagenesis kit (Stratagene,
La Jolla, CA), Fugene HD (Roche, Indianapolis, IN), 17
β-estradiol, Fulvestrant, DNase-free RNase A (Sigma,
St. Louis, MO), A/G plus agarose beads (Santa Cruz
Biotechnology, Santa Cruz, CA), proteinase K (Invitrogen,
Carlsbad, CA), anti-N-6-methyladenosine antibody
(Megabase Research, Lincoln, NE), QiaQuick PCR
purification kit (Qiagen, Valencia, CA), Branson sonifier
250, (Branson Corporation, Danbury, CT), StepOnePlus
real-time PCR system (Applied Biosystems, Foster City,
CA).
Figure 1.  Expression and transcriptional activities of
DamK9A-hERα fusion protein. (A). HeLa cells were transfected with
various plasmids as indicated and cell lysate was analyzed by Western
blot. MCF-7 and untransfected HeLa cell lysate were loaded as positive
and negative control, respectively.The same blot was detected with
anti-β-actin antibody as loading control. Molecular weights (Mw) are
indicated as kilodaltons (kDa). (B). Fusion protein transcriptional activities
in HeLa cells. Cells were co-transfected with various plasmids and
luciferase reporter vectors. Luciferase activities were measured 24 hours
after ligand treatment. Data are presented as mean +/- SEM.
Methods
Plasmid construction
DNA adenine methyltransferase open reading frame was
amplified from E. coli genomic DNA and inserted into a
pCMX vector.To generate the lysine 9 to alanine mutant
dam (DamK9A), AAG was changed to GCG with
QuickChange site-directed mutagenesis kit (Stratagene,
La Jolla, CA). A 3xFlag tag sequence was attached at
the N-terminus or C-terminus as a linker to generate
pCMX-N-DamK9A or pCMX-C-DamK9A vectors. A human
estrogen receptor α ORF was cloned and inserted into
either pCMX-N-DamK9A or pCMX-C-DamK9A vectors.
Cell culture, transfection and reporter assay
HeLa or MCF-7 cells were maintained in DMEM media
supplemented with 10% fetal bovine serum and 1x
nonessential amino acids (Invitrogen, Carlsbad, CA).
HeLa cells were transfected with lipofectamine 2000
(Invitrogen, Carlsbad, CA) and MCF-7 cells were
transfected with Fugene HD ((Roche, Indianapolis, IN)
following manufacturers’ protocols.
DamIP
Twenty four hours after transfection, cells were treated
with 100nM 17 β-estradiol for another 24 hours. Cells
were then collected and washed twice with phosphate
buffered saline (PBS). Cell pellets were resuspended with
lysis buffer (150mM NaCl, 10mM Tris pH8, 25mM EDTA
pH8, 0.5% SDS) and briefly sonicated to reduce viscosity.
DNase-free RNase A (Sigma, St. Louis, MO) was added
to final concentration of 10ug/mL and samples were
incubated at 37°C for 30 minutes. Proteinase K was then
added followed by overnight incubation at 50°C. Genomic
DNA was extracted from the deproteinized lysate by
phenol/chloroform extraction and ethanol precipitation.
Purified DNA was resuspended in TE buffer and sonicated
on ice until majority of the fragments were around 500
base pairs.
Five micrograms of sonicated DNA and 5pg of control
plasmid DNA were mixed in TE buffer and heated for 10
minutes in a boiling water bath and quenched on ice for
5 minutes.The control DNA plasmid contains a sequence
completely unrelated with mammalian genomes and is
fully methylated by growth in the standard DH5α stain.
The DNA solution was mixed with 0.11 volume of 10x
DamIP buffer (100mM Na-Phosphate pH 7.0, 3M NaCl,
0.5% Triton X-100). Five micrograms of
anti-N-6-methyladenosine antibody (Megabase Research,
Lincoln, NE) was added to the DNA solution and rotated
for one hour at room temperature. Buffer balanced A/G
plus agarose beads (Santa Cruz Biotechnology, Santa
Cruz, CA) were added to each sample and rotated for
another one hour at room temperature. Beads were
washed with 1xDamIP buffer 5 times and treated with
proteinase K overnight. Bound DNA was finally purified
with QiaQuick PCR purification kit (Qiagen, Valencia, CA)
and eluted in TE buffer. Eluted DNA was analyzed by
real-time quantitative PCR. PCR primer sequences are
available upon request. Normalized IP% is calculated as
the ratio of precipitated DNA over input DNA and
normalized with precipitation efficiency determined by the
control DNA signal (assume fully methylated plasmid
DNA is precipitated with efficiency of 1). All data are
presented as mean of three independent experiments +/-
SEM.
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Expression and activity of Dam fusion proteins
For proof of principle, we set out to test our new method
with the most widely studied nuclear receptor, human
estrogen receptor α (hERα).We fused an E. coli DNA
adenosine methyltransferase K9A mutant to both the
amino- and carboxyl-termini of hERα.The N-terminal
fusion protein expresses as a single band in HeLa cells
(Figure 1A).We further tested their transcriptional
activities in transiently transfected HeLa cells.The
N-terminal fusion protein, but not the C-terminal fusion
protein, retains ligand responsiveness, although its activity
is only approximately 20% of that of wild type hERα
(Figure 1B and data not shown).We used the N-terminal
fusion DamK9A-hERα in the following experiments.
Figure 2.  Illustration of the procedure of DamIP. DamK9A or
DamK9A fusion proteins are expressed in cells. Genomic DNA is purified,
sonicated and denatured before mixed with anti-N-6-methyladenine
antibodies. Methylated DNA recognized by the antibody is enriched and
analyzed by various methods, e.g. qPCR, microarray and next-generation
sequencing. Details are described in the Methods section.
DamIP in MCF-7 cells
Upon activation by agonist ligands, ERα regulates the
expression of most target genes by direct binding to
specific estrogen response elements (EREs). As
described in the Methods section and outlined in Figure
2, we transiently transfected MCF-7 cells with DamK9A
or DamK9A-hER and performed DamIP. Genomic DNA
was harvested, sonicated and denatured before
immunoprecipitation using an anti-N-6-methyladenosine
antibody (α-N6MA). Enriched DNA fragments were
analyzed by real-time quantitative PCR.We checked
several regions containing known ERα binding sites and
several regions without ERα binding sites [Carroll et al.,
2006; Labhart et al., 2005]. As shown in Figure 3A,
DamK9A-hERα introduces much more methylation into
fragments that contain known ERα binding sites than
Dam protein alone. In the regions without known ERα
binding sites, methylation introduced by DamK9A-hERα
is comparable with Dam protein alone ( Figure 3B).
DamK9A-hERα is clearly able to specifically introduce
N-6-adenosine methylation into the genome around
known ERα binding sites.
Figure 3.  RT-qPCR analysis of DamIP. Primers were designed to
amplify genomic regions with or without known ERE. DNA enriched with
DamIP from MCF-7 cells transfected with DamK9A-hER (Dam-ER) or
Dam alone was analyzed by qPCR. Data are presented as mean +/- SEM.
DamID uses wild type Dam protein, which methylates the
tetrameric sequence GATC that occurs on average once
in the genome in every 256 bp.Thus, the resolution of
DamID may be limited by the absence of potential
methylation target sequences in proximity to the binding
sites. In addition, the high activity of the native enzyme
introduces methyl tags relatively far from the binding sites.
The DamK9A mutant, which loses the recognition of the
first G and methylates the target sequence “ATC” [Horton
et al., 2006] should have four fold more potential
methylation target sequences and decreased activity,
both potentially increasing resolution.We tested
methylation around the well characterized FSIP ERE
[Carroll et al., 2006; Labhart et al., 2005]. Remarkably,
the robust DamK9A-hERα FSIP signal was not detected
in fragments more than 500bp away from the known ERα
binding region.We conclude that DamIP has good
resolution, comparable to that of the conventional ChIP
assay (Figure 4).
DamIP detects indirect ER regulation
In addition to direct binding to DNA, ERα can indirectly
regulate transcription by interacting with transcriptional
factors on their sites, including Sp1 and AP-1 (jun/fos)
[Nilsson et al., 2001].We investigated two known sites
of indirect ERα regulation. As shown in Figure 5C,
DamK9A-hERα but not Dam alone specifically introduced
methylation in these regions.
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Methods A new method for DNA binding element identificationFigure 4.  DamIP has great resolution. A series of primers were
designed to amplify the regions upstream of the FSIP locus that contains
known ERE.These targeted regions are about 500bp from each other
and designated as -2k, -1.5k, -1k, -0.5k, respectively.The specific
modification introduced by DamK9A-hER is only observed at the FSIP
locus.
Some ERα binding sites are located several thousand
base pairs upstream of the transcription starting sites.
Regulation of gene expression through these distal
enhancers may require communication between the
enhancers and proximal promoters via long range
chromosome looping [Barnett et al., 2008; Pan et al.,
2008]. Carbonic anhydrase XII (CA12) gene encodes a
zinc metalloenzyme, which is overexpressed in certain
cancers, including breast cancer. ERα strongly regulates
the expression of C12 through a distal ERα binding site
located about 6kb upstream of the transcription start site.
Communication between the distal enhancer and proximal
promoter after ER activation is not apparent in standard
ChIP, but can by detected by the chromatin conformation
capture assay [Barnett et al., 2008].We analyzed the
distal enhancer and proximal promoter regions of CA12
gene with DamIP. As shown in Figure 5A, DamK9A-hERα
specifically introduced methylation at the ERE containing
distal enhancer region, but Dam protein alone did not.
For the proximal promoter region, which does not contain
a known ERE, DamK9A-hERα also introduced increased
methylation compared with Dam protein alone, indicating
indirect interaction/communication of ERα with this region.
Another known ER target gene cathepsin D (CTSD) has
multiple EREs in the distal enhancer region, and
conventional ChIP detects ERα recruitment after ligand
treatment at the enhancer regions but not the promoter
[Carroll et al., 2006]. DamIP shows ERα interaction at
both regions (Figure 5B), indicating that ER may regulate
cathepsin D expression through a similar chromatin
looping mechanism as CA12.This result is consistent
with the finding that the distal ERE enhancer regulates
CTSD expression through long range chromosomal
looping mechanism [Bretschneider et al., 2008].
Discussion
Here we describe a novel method to identify DNA binding
elements in vivo. Our method uses a mutant form of E.
coli Dam joined to the protein of interest, which can
introduce N-6-adenosine methylation into genomic DNA
around sites bound by the fusion protein.This modification
is not present in mammalian DNA, and the specifically
tagged DNA can be enriched with antibody and analyzed
by various assays.The effectiveness of this technology
is clearly validated by the results described here, which
suggest that it is very sensitive. Eleven out of 12 known
ER binding sites that we tested showed significant
enrichment compared with control.We are in the process
of using massive parallel sequencing to analyze DamIP
samples, which will provide a genome-wide comparison
of DamIP with conventional ChIP.
Figure 5.  DamIP identifies indirect regulation by ER. ER can
regulate gene expression through long range chromosome looping (A,
B) or binding with other transcriptional factors (C). Carbonic anhydrase
XII (C12) and cathepsin D (CTSD) enhancers contain functional EREs
but not promoter regions, however, DamIP indicates ER communicates
with the ERE-less promoter regions during transcription. ER regulation
through interaction with AP1 (C, left panel) or Sp1 (C, right panel) can
also be detected by DamIP.
The introduction of the Dam mutation was important for
two reasons.The first is that wild type Dam is a very
active enzyme and its expression in mammalian cells can
rapidly result in methylation of the whole genome.The
second is that the GATC specificity of the wild type
enzyme limits the potential resolution of the technique.
We screened several Dam mutants with decreased
activity and specificity in DamIP and found that the
DamK9A mutant showed the best signal to noise ratio.
This mutant decreases specificity for the initial G [Horton
et al., 2006], increasing the frequency of potential sites
by fourfold.
There are several technical issues that confronted the
development of the DamIP technology, and others that
must be addressed in its potential application to other
proteins of interest. During the preparation of plasmids
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propagated in Dam/Dcm negative strains are methylated.
This is likely due to the leaky expression of Dam proteins
driven by the mammalian promoter in the plasmid.
Fragments of these methylated plasmids are recognized
and precipitated by the α-N6MA antibody.These
fragments did not interfere with qPCR analysis in our
study, but may cause potential background problems in
certain analysis methods, e.g. microarray.This potential
problem could be easily circumvented using a virus-based
expression system or generating stable cell lines.
However, methylated plasmids can also be useful in
DamIP.We prepared a fully methylated plasmid
containing a completely unrelated sequence from D.
discoideum. A constant amount of this control plasmid
equivalent to that of a single copy gene was added to
each sample prior to immunoprecipitation. Analyzing the
amount of the control plasmid in the final enriched DNA
provides an internal control to monitor the precipitation
efficiency of individual samples.
During the development and optimization of DamIP, we
tested a variety of different salt/detergent concentrations
and antibody binding beads to identify the best
immunoprecipitation condition.With all of these efforts,
we still observed some background binding with
unmethylated DNA. However, this background was largely
eliminated by generating single strand DNA conjugated
agarose that was pre-incubated with the
anti-N-6-methyladenosine antibody.
As shown in Figure 1, the fusion protein DamK9A-hERα
showed reduced transcriptional activities compared with
the wild type hERα.This was partially due to the reduced
expression of the fusion protein, but more detailed studies
indicated decreased activity of DamK9A-hERα and other
fusion proteins tested.The basis for this decreased
activity is not clear, but could reflect either simple steric
effects or more specific impact of the Dam protein itself.
As with other fusion approaches, it is essential to
determine the activity of the fusion proteins and may be
necessary to employ a range of amino- and
carboxyl-terminal fusion strategies.
DamIP relies on an antibody against N-6-methyladenine.
We initially obtained an antibody from Megabase
Research, which worked very well for the studies
described here. Unfortunately, this company no longer
exists and the antibody is no longer available. However,
several groups have generated similar antibodies and
another company (SYSY, Goettingen, Germany) also
provides α-N6MA antibody that has good affinity against
N6MA and works well in DamIP.We are now generating
our own antibody according to published protocols
[Erlanger and Beiser, 1964; Lopez et al., 2003] and the
crude sera also works.
Compared with conventional ChIP assay, our method
has two major advantages: 1) no need for protein-specific
antibodies; 2) no need for formaldehyde crosslinking.
Conventional ChIP requires a high quality antibody
against the protein of interest to allow satisfactory
enrichment over the background, and such antibodies
are not always available. In contrast, our method only
needs the antibody against N-6-methyladenine. A
potentially tricky and cumbersome step of the
conventional ChIP assay is the crosslinking of
protein-DNA complexes with formaldehyde. In addition
to the toxicity of formaldehyde, crosslinking with
formaldehyde is difficult under certain conditions,
especially when the ChIP assay is applied to whole tissue
or organs. In general, DamIP shows comparable or better
enrichment compared with conventional ChIP.When
using lentiviral transfection to express Dam-ER proteins
in MCF-7 cells, we observed more than 100 fold
enrichment at the FSIP ERE by DamIP compared with
about 17 fold by conventional ChIP assay [Labhart et al.,
2005].
In DamIP, the methyl tags are covalently attached to the
genomic DNA.We assume that this covalent modification
is essentially permanent in eukaryotic cells, although
there is no mechanism to replicate it and it is possible
that it could be recognized as DNA damage and repaired.
However, the modification is not affected by harsh
treatments to remove proteins prior to DamIP, and most
of the procedures can be conveniently performed at room
temperature.This property of DamIP makes it particularly
suitable for in vivo identification of DNA binding sites.
A limitation of DamIP relative to ChIP is the reliance on
expression of the exogenous fusion protein rather than
the endogenous protein. In this, DamIP resembles other
techniques that rely on fusion proteins, for example the
BirA fusions that rely on the high affinity avidin-biotin
interaction rather than antibodies to purify crosslinked,
specifically bound DNA fragments [Kim et al., 2009].
An important qualitative difference between DamIP and
ChIP is that conventional ChIP gives a snap-shot of
DNA-protein binding profile at the time of crosslinking,
while DamIP provides an cumulative profile of
DNA-protein interaction over time.Thus, DamIP cannot
be used for time course studies such as those used to
follow events after estradiol administration [Metivier et
al., 2003]. In fact, we observed a low level of specific
methylation at ERα binding sites in MCF7 cells even in
the absence of estradiol or in the presence of antagonist.
We believe this is the result of cumulative methylation
when ERα briefly interacts with its target in the presence
of antagonist or in the absence of ligands, which is hard
to detect with conventional ChIP assay.
However, DamIP could be used to identify an increasing
range of primary and potential secondary targets over
time after ligand addition. For example, recruitment of
ERα at the proximal CTSD promoter is usually hard to
detect by conventional ChIP probably because the
recruitment is transient and time-dependent
[Bretschneider et al., 2008; Carroll et al., 2006; Shang et
al., 2000]. However, DamIP can readily detect this
interaction (Figure 5B), potentially as the result of
cumulative ERα recruitment profile over the period of
ligand treatment. Particularly when combined with
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Methods A new method for DNA binding element identificationtetracycline [Corbel and Rossi, 2002] or ecdysone [No et
al., 1996] inducible systems, DamIP will provide another
option to study DNA-protein interactions in vivo.With the
development and implementation of next generation
massive parallel sequencing technology and
bioinformatics, DamIP will provide an excellent tool to
study and identify binding sites or target genes of
transcriptional factors.
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